vs

Side-by-side financial comparison of AerSale Corp (ASLE) and Inogen Inc (INGN). Click either name above to swap in a different company.

AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $68.6M, roughly 1.3× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 0.2%).

AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

ASLE vs INGN — Head-to-Head

Bigger by revenue
ASLE
ASLE
1.3× larger
ASLE
$90.9M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+7.4% gap
INGN
3.4%
-4.0%
ASLE
More free cash flow
ASLE
ASLE
$11.7M more FCF
ASLE
$9.8M
$-1.9M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
0.2%
ASLE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASLE
ASLE
INGN
INGN
Revenue
$90.9M
$68.6M
Net Profit
$5.4M
Gross Margin
34.1%
51.4%
Operating Margin
7.8%
-13.6%
Net Margin
5.9%
Revenue YoY
-4.0%
3.4%
Net Profit YoY
99.7%
EPS (diluted)
$0.10
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASLE
ASLE
INGN
INGN
Q4 25
$90.9M
$68.6M
Q3 25
$71.2M
$79.1M
Q2 25
$107.4M
$79.2M
Q1 25
$65.8M
$68.5M
Q4 24
$94.7M
$66.3M
Q3 24
$82.7M
$74.9M
Q2 24
$77.1M
$74.4M
Q1 24
$90.5M
$63.1M
Net Profit
ASLE
ASLE
INGN
INGN
Q4 25
$5.4M
Q3 25
$-120.0K
$-5.3M
Q2 25
$8.6M
$-4.2M
Q1 25
$-5.3M
$-6.2M
Q4 24
$2.7M
Q3 24
$509.0K
$-6.0M
Q2 24
$-3.6M
$-5.6M
Q1 24
$6.3M
$-14.6M
Gross Margin
ASLE
ASLE
INGN
INGN
Q4 25
34.1%
51.4%
Q3 25
30.2%
52.2%
Q2 25
32.9%
52.2%
Q1 25
27.3%
53.1%
Q4 24
31.4%
54.7%
Q3 24
28.6%
55.2%
Q2 24
28.2%
57.4%
Q1 24
31.8%
54.5%
Operating Margin
ASLE
ASLE
INGN
INGN
Q4 25
7.8%
-13.6%
Q3 25
4.0%
-9.0%
Q2 25
11.7%
-7.7%
Q1 25
-10.1%
-11.2%
Q4 24
5.2%
-17.2%
Q3 24
2.4%
-10.4%
Q2 24
-2.4%
-9.5%
Q1 24
5.2%
-25.8%
Net Margin
ASLE
ASLE
INGN
INGN
Q4 25
5.9%
Q3 25
-0.2%
-6.7%
Q2 25
8.0%
-5.2%
Q1 25
-8.0%
-9.0%
Q4 24
2.9%
Q3 24
0.6%
-8.0%
Q2 24
-4.7%
-7.5%
Q1 24
6.9%
-23.1%
EPS (diluted)
ASLE
ASLE
INGN
INGN
Q4 25
$0.10
$-0.26
Q3 25
$0.00
$-0.20
Q2 25
$0.18
$-0.15
Q1 25
$-0.10
$-0.25
Q4 24
$0.05
$-0.41
Q3 24
$0.01
$-0.25
Q2 24
$-0.07
$-0.24
Q1 24
$0.12
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASLE
ASLE
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$4.4M
$103.7M
Total DebtLower is stronger
$1.3M
Stockholders' EquityBook value
$424.4M
$192.2M
Total Assets
$640.5M
$298.6M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASLE
ASLE
INGN
INGN
Q4 25
$4.4M
$103.7M
Q3 25
$5.3M
$106.5M
Q2 25
$5.7M
$103.7M
Q1 25
$4.7M
$118.9M
Q4 24
$4.7M
$113.8M
Q3 24
$9.8M
$105.7M
Q2 24
$4.3M
$97.9M
Q1 24
$2.6M
$107.4M
Total Debt
ASLE
ASLE
INGN
INGN
Q4 25
$1.3M
Q3 25
$1.5M
Q2 25
$907.0K
Q1 25
$1.1M
Q4 24
$1.2M
Q3 24
$376.0K
Q2 24
$522.0K
Q1 24
$3.5M
Stockholders' Equity
ASLE
ASLE
INGN
INGN
Q4 25
$424.4M
$192.2M
Q3 25
$417.1M
$197.2M
Q2 25
$415.9M
$199.5M
Q1 25
$406.5M
$198.0M
Q4 24
$455.6M
$173.9M
Q3 24
$451.5M
$185.4M
Q2 24
$449.8M
$187.6M
Q1 24
$452.0M
$191.9M
Total Assets
ASLE
ASLE
INGN
INGN
Q4 25
$640.5M
$298.6M
Q3 25
$646.3M
$307.0M
Q2 25
$646.7M
$312.0M
Q1 25
$646.1M
$308.4M
Q4 24
$604.7M
$296.2M
Q3 24
$601.5M
$306.2M
Q2 24
$598.7M
$308.9M
Q1 24
$571.7M
$315.6M
Debt / Equity
ASLE
ASLE
INGN
INGN
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASLE
ASLE
INGN
INGN
Operating Cash FlowLast quarter
$11.4M
$-943.0K
Free Cash FlowOCF − Capex
$9.8M
$-1.9M
FCF MarginFCF / Revenue
10.8%
-2.8%
Capex IntensityCapex / Revenue
1.7%
1.4%
Cash ConversionOCF / Net Profit
2.11×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASLE
ASLE
INGN
INGN
Q4 25
$11.4M
$-943.0K
Q3 25
$-8.9M
$2.2M
Q2 25
$19.8M
$4.3M
Q1 25
$-45.2M
$-16.8M
Q4 24
$37.5M
$-3.0M
Q3 24
$10.4M
$7.0M
Q2 24
$-15.3M
$6.7M
Q1 24
$-21.5M
$-4.7M
Free Cash Flow
ASLE
ASLE
INGN
INGN
Q4 25
$9.8M
$-1.9M
Q3 25
$-9.8M
$1.6M
Q2 25
$18.6M
$3.7M
Q1 25
$-47.6M
$-17.1M
Q4 24
$32.3M
$-3.3M
Q3 24
$8.9M
$5.3M
Q2 24
$-18.9M
$6.6M
Q1 24
$-25.0M
$-6.1M
FCF Margin
ASLE
ASLE
INGN
INGN
Q4 25
10.8%
-2.8%
Q3 25
-13.8%
2.0%
Q2 25
17.3%
4.6%
Q1 25
-72.4%
-24.9%
Q4 24
34.0%
-5.0%
Q3 24
10.7%
7.1%
Q2 24
-24.6%
8.9%
Q1 24
-27.7%
-9.6%
Capex Intensity
ASLE
ASLE
INGN
INGN
Q4 25
1.7%
1.4%
Q3 25
1.3%
0.7%
Q2 25
1.1%
0.9%
Q1 25
3.7%
0.4%
Q4 24
5.6%
0.5%
Q3 24
1.9%
2.2%
Q2 24
4.7%
0.1%
Q1 24
3.9%
2.1%
Cash Conversion
ASLE
ASLE
INGN
INGN
Q4 25
2.11×
Q3 25
Q2 25
2.31×
Q1 25
Q4 24
13.89×
Q3 24
20.52×
Q2 24
Q1 24
-3.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASLE
ASLE

Products$57.8M64%
Maintenance$23.2M26%
Leasing Arrangements$9.9M11%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons